Argos Therapeutics
BioTech/Drugs - Durham, NC, US
Argos Therapeutics Employees
Argos Therapeutics Senior Management
Argos Therapeutics Details
Argos Therapeutics is an immuno-oncology company focused on the development and commercialization of individualized immunotherapies for the treatment of cancer and infectious diseases using its Arcelis® technology platform. Argos' most advanced product candidate, rocapuldencel-T, is being evaluated in the pivotal ADAPT Phase 3 clinical trial for the treatment of metastatic renal cell carcinoma (mRCC). In addition, rocapuldencel-T is being studied in Phase 2 investigator-initiated clinical trials as neoadjuvant therapy for renal cell carcinoma (RCC) and for the treatment of non-small cell lung cancer (NSCLC). Argos is also developing a separate Arcelis®-based product candidate, AGS-004, for the treatment of human immunodeficiency virus (HIV), which is currently being evaluated in an investigator-initiated Phase 2 clinical trial aimed at HIV eradication in adult patients.
Argos Therapeutics Technologies
Frameworks and Programming Languages
ASP.NET
Email Providers
Outlook
Load Balancers
Apache
CMS
WordPress.org
Other
Microsoft Office 365
Analytics and Tracking
Omniture (Adobe)